SG11201811368SA - Sleep improving agent - Google Patents

Sleep improving agent

Info

Publication number
SG11201811368SA
SG11201811368SA SG11201811368SA SG11201811368SA SG11201811368SA SG 11201811368S A SG11201811368S A SG 11201811368SA SG 11201811368S A SG11201811368S A SG 11201811368SA SG 11201811368S A SG11201811368S A SG 11201811368SA SG 11201811368S A SG11201811368S A SG 11201811368SA
Authority
SG
Singapore
Prior art keywords
improving agent
sleep improving
protein expression
heat shock
inducing agent
Prior art date
Application number
SG11201811368SA
Inventor
Kazunori Goto
Jun Nakahigashi
Atsuya Sato
Yosuke Hirayama
Moeri Horikoshi
Noriyuki Kouda
Syoichiro Inoue
Ikutaro Sato
Manami Kato
Original Assignee
Amino Up Chemical Co Ltd
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amino Up Chemical Co Ltd, Otsuka Pharma Co Ltd filed Critical Amino Up Chemical Co Ltd
Publication of SG11201811368SA publication Critical patent/SG11201811368SA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/31—Foods, ingredients or supplements having a functional effect on health having an effect on comfort perception and well-being
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/322—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the nervous system or on mental function

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The present invention provides a heat shock protein expression-inducing agent, more specifically, a heat shock 5 protein expression-inducing agent comprising a compound represented by formula (I): 0 H / -4 ... .s 7 ,.- R ' * N H N 0 wherein R is a lower alkyl, phenyl, or hydroxyphenyl, or a salt thereof. 10
SG11201811368SA 2016-05-26 2017-05-26 Sleep improving agent SG11201811368SA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2016105477 2016-05-26
PCT/JP2017/019644 WO2017204321A1 (en) 2016-05-26 2017-05-26 Sleep improving agent

Publications (1)

Publication Number Publication Date
SG11201811368SA true SG11201811368SA (en) 2019-01-30

Family

ID=60412712

Family Applications (2)

Application Number Title Priority Date Filing Date
SG11201811368SA SG11201811368SA (en) 2016-05-26 2017-05-26 Sleep improving agent
SG10201912843YA SG10201912843YA (en) 2016-05-26 2017-05-26 Sleep improving agent

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG10201912843YA SG10201912843YA (en) 2016-05-26 2017-05-26 Sleep improving agent

Country Status (8)

Country Link
US (3) US20190201395A1 (en)
EP (1) EP3466427A4 (en)
JP (2) JP7381000B2 (en)
KR (2) KR20230047198A (en)
CN (1) CN109562110A (en)
SG (2) SG11201811368SA (en)
TW (1) TWI733817B (en)
WO (1) WO2017204321A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11201811368SA (en) 2016-05-26 2019-01-30 Amino Up Chemical Co Ltd Sleep improving agent
JP7020797B2 (en) * 2017-04-25 2022-02-16 キリンホールディングス株式会社 Composition for autonomic nervous regulation

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7202279B1 (en) * 1998-02-11 2007-04-10 Georgetown University Cyclic dipeptides and azetidinone compounds and their use in treating CNS injury and neurodegenerative disorders
KR100785182B1 (en) * 2000-06-26 2007-12-11 워너-램버트 캄파니 엘엘씨 Gabapentin Analogues for Sleep Disorders
JP2003252896A (en) 2002-02-26 2003-09-10 Toyohashi University Of Technology Method of synthesis for cyclic peptide utilizing high- temperature and high-pressure water
WO2003104441A2 (en) * 2002-06-10 2003-12-18 Ramot At Tel Aviv University Ltd. Novel bacterial strain, compositions derived therefrom and methods of using same for treating beta-ap-associated deseases
EP1664050B1 (en) * 2003-09-03 2015-12-09 Neuren Pharmaceuticals Limited Neuroprotective bicyclic compounds and pharmaceutical compositions containing them
EP2168955B1 (en) * 2007-05-29 2014-03-05 Osaka Bioscience Institute Sleep-improving agent
JP5058379B2 (en) 2009-12-25 2012-10-24 サントリーホールディングス株式会社 Learning motivation improver
TW201219360A (en) 2010-10-01 2012-05-16 Otsuka Pharma Co Ltd Heat shock protein expression inducer
JP2013071902A (en) * 2011-09-27 2013-04-22 Ltt Bio-Pharma Co Ltd Heat shock protein expression inducer
AR088064A1 (en) * 2011-09-29 2014-05-07 Abbvie Inc OCTAHYDROPIRROLO [1,2-A] PIRAZINA SULFONAMIDS REPLACED AS CALCIUM CHANNEL BLOCKERS
JP5877063B2 (en) * 2011-12-28 2016-03-02 花王株式会社 Coffee extract
JP6574769B2 (en) * 2013-07-25 2019-09-11 ニューレン ファーマシューティカルズ リミテッド Bicyclic compounds and their use in the treatment of autism spectrum disorders and neurodevelopmental disorders
WO2015194034A1 (en) 2014-06-20 2015-12-23 サントリーホールディングス株式会社 Uric acid level lowering agent
DE102014117246B4 (en) 2014-11-25 2018-11-15 Heraeus Deutschland GmbH & Co. KG Method for producing a substrate adapter, substrate adapter and method for contacting a semiconductor element
KR102019472B1 (en) * 2015-10-05 2019-09-06 주식회사 엘지화학 Battery module and battery pack including the same
SG11201811368SA (en) 2016-05-26 2019-01-30 Amino Up Chemical Co Ltd Sleep improving agent

Also Published As

Publication number Publication date
US20190201395A1 (en) 2019-07-04
WO2017204321A1 (en) 2017-11-30
KR20230047198A (en) 2023-04-06
EP3466427A4 (en) 2020-02-05
JP2022078217A (en) 2022-05-24
EP3466427A1 (en) 2019-04-10
JP7381000B2 (en) 2023-11-15
US20230017155A1 (en) 2023-01-19
US11478473B2 (en) 2022-10-25
KR20190028663A (en) 2019-03-19
US20200246335A1 (en) 2020-08-06
TWI733817B (en) 2021-07-21
SG10201912843YA (en) 2020-02-27
TW201808292A (en) 2018-03-16
KR102514031B1 (en) 2023-03-27
CN109562110A (en) 2019-04-02
JPWO2017204321A1 (en) 2019-04-04

Similar Documents

Publication Publication Date Title
BR112017006253A2 (en) new compounds
MA40301B1 (en) Indolecarboxamide compounds useful as kinase inhibitors
GEP20207105B (en) 1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2yl carbamate derivatives as magl inhibitors
SG11201804121RA (en) Novel biphenyl compound or salt thereof
MX2021011972A (en) 2-(phenyloxy or phenylthio)pyrimidine derivatives as herbicides.
CL2016000581A1 (en) Bicyclic azol pesticides substituted by heterocycle.
PH12015502031A1 (en) Tetrahydropyrrolothiazine compounds
PH12020500673A1 (en) Compounds
PH12019500480A1 (en) Pyridine compound
MX2022008434A (en) Pyridazinone herbicides.
PH12014502211A1 (en) Alkyl phenyl sulfide derivative and pest control agent
EA201691439A1 (en) Pyrimidiniloxibenzene derivatives as herbicides
EA201400137A1 (en) FUNGICIDE ALKYL SUBSTITUTED 2- [2-CHLORO-4- (4-CHLOROPHENOXY) PHENYL] -1- [1,2,4] TRIAZOL-1-IL-ETHANOLIC
EA201690019A1 (en) AMINOTRIASIN DERIVATIVE AND CONTAINING ITS PHARMACEUTICAL COMPOSITION
EA201790125A1 (en) Piperidinone Herbicides
RS54730B1 (en) Inhibitors of beta-secretase
AR095523A1 (en) PIRIDIN-4-ILO DERIVATIVES
EA201990279A1 (en) HERBICIDAL COMPOSITIONS CONTAINING PHENYLPYRIMIDINES
EA201991253A1 (en) BENZODIAZOLIUM COMPOUNDS AS ENAC INHIBITORS
MY178881A (en) Novel aqueous composition
MX2016005319A (en) Pesticidal compositions and related methods.
EA202090368A1 (en) LYSOPHOSPHATID ACID RECEPTOR COMPOUNDS 1 (LPAR1)
EA201991241A1 (en) METHOD FOR PRODUCING METHOXYMETHYLPYRIDINE DICARBOXYLATE
EA201591915A1 (en) COMPOUNDS OF PHENOXYETHYL DIHYDRO-1H-IZOHINOLINA
SG11201810725WA (en) Novel β-lactamase inhibitors